Search Results 101-110 of 16012 for inactivated vaccines

  1. Influenza virus vaccine, live (nasal route) - Side effects & uses - Mayo Clinic

    Influenza virus vaccine is used to prevent infection by the influenza viruses. The vaccine works by causing your body to produce its own protection (antibodies) ...

  2. Smallpox and mpox vaccine, live (intradermal route, subcutaneous route) - Mayo Clinic

    Smallpox mpox vaccine, live non-replicating is used as an active immunization against smallpox and mpox infection in patients who may be at high risk to have ...

  3. measles vaccine Archives - Mayo Clinic News Network

    ... vaccines are live, attenuated vaccines. The “killed” or inactivated version used from 1963 through 1967 does not count. If you received unspecified measles ...

  4. Ublituximab-xiiy (intravenous route) - Side effects & uses - Mayo Clinic

    Diphtheria Toxoid, Adsorbed; Ebola Zaire Vaccine, Live; Haemophilus B Vaccine; Hepatitis A Vaccine, Inactivated ... vaccines at least 2 weeks, before starting ...

  5. Varicella virus vaccine, live (intramuscular route, subcutaneous route) - Side effects & uses - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against the virus. Varicella (commonly known as chickenpox) is an infection ...

  6. Infectious Diseases A–Z: What are the risks of vaccination?

    All vaccines come with a risk of side effects. With that knowledge, Dr. Gregory Poland, director of the Mayo Clinic Vaccine Research Group says, ...

  7. Teplizumab-mzwv (intravenous route) - Side effects & uses - Mayo Clinic

    Poliovirus Vaccine, Inactivated; Poliovirus Vaccine, Live; Rabies Vaccine ... Live virus vaccines should not be given for at least 8 weeks before start ...

  8. Rabies vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

    This is called post-exposure prophylaxis. Rabies vaccine may also be given ahead of time to persons who have a high risk of getting infected with rabies virus.

  9. Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and Associated Precursors - Mayo Clinic

    About this study. The primary objective of this study is to determine the immunogenicity of FDA approved COVID-19 vaccination in patients with hematologic ...

  10. Mayo Clinic Minute: 3 misconceptions about COVID-19 and flu vaccines

    Misconceptions about influenza and COVID-19 vaccines may make some people hesitant to roll up their sleeves. Hear from a Mayo Clinic expert.